| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10969344 | Vaccine | 2011 | 13 Pages |
Abstract
⺠This review summarizes findings of the clinical development programme. ⺠Vaccination in adults, children and adolescents, the elderly and special patient populations. ⺠Determination of the optimal dose, conventional and rapid schedules, safety, immunopersistence. ⺠Comprehensive research programme demonstrated strong immunogenicity and safety of FSME-IMMUN®. ⺠An effective and well-tolerated solution to the endemic risk of TBE virus infection.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alexandra Loew-Baselli, Eva Maria Poellabauer, Borislava G. Pavlova, Sandor Fritsch, Clair Firth, Robert Petermann, P. Noel Barrett, Hartmut J. Ehrlich,